KLK3 and posterior cortical atrophy: The decreased incidence in low-risk disease can at least partly be due to the 2012 change from the United States Preventive Services Task Force (USPSTF) [4], which concluded that PCa screening using prostate-specific antigen (PSA) should not be recommended [4].